Chargement en cours...
S9511: A Southwest Oncology Group Phase II Study of Trimetrexate, 5FU, and Leucovorin in Unresectable or Metastatic Adenocarcinoma of the Stomach
OBJECTIVE: The primary objective of this trial was to evaluate the response rate for trimetrexate (TMTX) in conjunction with 5FU and leucovorin (LV) (=TFL) in the treatment of advanced gastric cancer in a phase II, cooperative group setting. METHODS: Patients with locally advanced, unresectable, or...
Enregistré dans:
| Auteurs principaux: | , , , , , , , , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
2010
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2967385/ https://ncbi.nlm.nih.gov/pubmed/19770625 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/COC.0b013e318199fb84 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|